In this episode, @egledie talks to former UEG President @DignassAxel about leading through crisis. Axel shares lessons from COVID-19 on empathy, resilience, and spotting toxic leadership.
💬 "A boss gives orders, a leader inspires and motivates."
🔗 https://t.co/Zlw5se73Jg
💡FDA vs. EMA on #UC trial guidance
https://t.co/UqxH9D9yfg
👉FDA pushes full colonoscopy & maintenance of remission as new endpoints
👉EMA remains more flexible
⚠️ Lack of harmonization = more trials, slower approvals, patient burden.
#IBD#UC#FDA#EMA#ClinicalTrials
GALAXI 2 and 3 trials of guselkumab maintenance in patients with Crohns disease just published
🌟Guselkumab superior to placebo and ustekinumab
@TheLancet@LancetGastroHep@geteccu@sepdigestiva@aegastro
➡️ https://t.co/q6yG2KHjFe
💎Join us tomorrow 06/17 for our Virtual Global Visiting Professorship live broadcast with Prof. @DignassAxel@ClevelandClinic
Topic - "Teaching New Tricks to An Old Horse: 5-ASA and Immunomodulator Use in IBD".
Register here👉: https://t.co/MXWVymbX2I
Großartiger Auftakt zum 36. Kolloquium CED im Rahmen der DGIM 2025 mit Unterstützung der Falk Foundation. Full House. Tolle Vortäge, ausgezeichnete Referenten und Moderatoren.
#falkfoundation,#axel Dignass,#irina Blumenstein
FCP is better for colonic > small bowel (SB) inflammatiin, but how accurate is it in proximal vs. distal SB?
Using VCE as gold standard, our
@sheba_medical brilliant fellow @OffirU reports in @JCC_IBD a dilutional gradient of calpro along the SB !
https://t.co/1bizDkwNaG